Skip to content
MMetabolicMomsTHE MAGAZINE FOR MOTHERS ON GLP-1
Menu

Feature · The Body

GLP-1 Constipation and Gut Changes — and What Actually Helps

The slowed stomach that curbs appetite also slows the whole works. Why constipation is so common on a GLP-1, the fixes that help, and the red flags.

By Margaux Ellery, Editor-in-Chiefa mother on the MetabolicMoms desk, not a treating clinician

Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.

On this page

The side effect nobody warns you about at the dinner table

Everyone warns you about the nausea. Almost nobody warns you about the other end. You start a GLP-1, the appetite quiets, the weight starts to move — and somewhere in the first few weeks you realize you have not gone in days, that things have slowed to a stop and nobody mentioned this part. It is one of the most common experiences on these drugs and one of the least discussed, probably because "let me tell you about my constipation" is not dinner-party conversation. So let us just say it plainly, explain why it happens, and get to what actually helps.

Why a GLP-1 backs up the works

The mechanism is not a mystery — it is the same mechanism that makes the drug work. GLP-1 medications slow how quickly the stomach empties, which is a large part of why you feel full on less food. But the slowdown does not politely stop at the stomach. The whole digestive tract runs at a more leisurely pace, and slower transit means the colon has more time to pull water out of what is passing through, leaving stool harder, drier, and slower to move. A comprehensive review of the gastrointestinal effects of these drugs describes exactly this: delayed gastric emptying and slowed motility as the through-line behind the class's GI symptoms, constipation among them1. Add the fact that you are now eating much less — less food, often less fiber, and less fluid than you realize — and you have every ingredient for a backup.

So it is not that something has gone wrong. It is the drug doing its job, with a predictable downstream cost.

How common is it, really

Common enough that you are not an outlier. In the pivotal trial of semaglutide for weight management, constipation was among the frequently reported gastrointestinal effects, sitting alongside nausea and diarrhea as one of the signature GI complaints of the class2. A large systematic review and meta-analysis of GLP-1 medications and gastrointestinal adverse events confirms the pattern across the class — constipation is a real, measurable, elevated risk, not an anecdote — while also being reassuring that the serious gut complications are far rarer3. Translation: expect it to be plausible, plan for it, and know that for the overwhelming majority it is a nuisance to manage rather than a danger.

This is the drug working, with a bill attached at the other end. You pay it with water, fiber, and movement — not by white-knuckling it.

What actually helps — in the order to try it

The fixes are unglamorous and they work. Try them roughly in this order.

  1. Water, more than you think. Slowed transit dries stool out, so you are fighting that with fluid. This is the first lever and the most underused — most women who fix their GLP-1 constipation fix a good part of it here.
  2. Fiber, but ramped gently. Both soluble fiber (oats, beans, chia, psyllium) and the produce you may have quietly stopped eating help — but add it gradually and with water, because a wall of fiber on a slowed gut can bloat you instead. A daily psyllium supplement is a reasonable, evidence-friendly staple.
  3. Move your body. Walking and general activity genuinely stimulate the bowel. It does not have to be a workout; a real walk most days moves things along — and it doubles as the resistance-and-movement habit that protects muscle as you lose.
  4. Do not skip meals entirely. On a tiny appetite it is tempting to eat almost nothing, but food itself triggers the reflex that moves the colon. Small, regular, fiber-containing meals beat a single sparse one.
  5. Ask about an OTC option. If the basics are not enough, an osmotic laxative such as polyethylene glycol is commonly used and worth raising with your prescriber — the same clinician conversation that should already be covering what to expect as a first-timer. This is routine, not a failure.

Most cases resolve with the first three. If the constipation is fierce right after a dose increase, that is also a fair reason to talk about a slower titration rather than pushing to the next dose on schedule.

The red flags — when it is not just constipation

Here is the part that matters most, because ordinary constipation and a genuine emergency can start in the same place. Stop and call your clinician — or seek urgent care — if you have severe or persistent abdominal pain, a belly that is swollen and you cannot pass gas or stool at all, or relentless vomiting. That combination can signal a bowel obstruction or ileus — the gut effectively stalling — which, while uncommon, is the serious end of the same motility story and is documented among the rarer gastrointestinal events with these drugs3. Severe, boring-through abdominal pain also warrants prompt evaluation on its own. The point is not to frighten you off a medication that is a nuisance for most and a danger for very few; it is to make sure you know the line between "annoying" and "call someone now," so you never sit at home wondering.

The bottom line

GLP-1 constipation is the predictable tax on the mechanism that makes the drug work — a slowed gut that also slows the exit. For most women it yields to water, gently-ramped fiber, movement, and, if needed, a simple OTC laxative, with a slower titration as a fallback. Keep the red flags in your back pocket. And choose a program that treats this as a conversation, not a shipping label — one that titrates thoughtfully and answers the phone when your gut has questions. That is why CoreAge Rx sits first on our board of GLP-1 programs for women, earning the highest score on the factors our Editors' Rating weighs; some links here may earn us a referral fee. For the full picture, see our complete guide for moms. This feature is educational only and is not medical advice; confirm anything worrying with your own clinician.

Frequently asked questions

Why do GLP-1s cause constipation?

The same slowed stomach emptying that curbs your appetite also slows the whole digestive tract. Slower transit gives the colon more time to pull water out of stool, leaving it harder and drier — and because you are eating much less food, fiber, and fluid than before, the effect compounds. It is the medication working as intended, with a downstream cost, not a sign something has gone wrong.

What helps GLP-1 constipation?

In order: drink more water than you think you need; add fiber gradually and with fluid (oats, beans, chia, or a daily psyllium supplement); walk and stay active; and do not skip meals entirely, since food triggers the reflex that moves the colon. If the basics are not enough, an osmotic laxative such as polyethylene glycol is commonly used — raise it with your prescriber. Fierce constipation right after a dose increase is also a fair reason to ask about slower titration.

When is constipation on a GLP-1 an emergency?

Stop and call your clinician or seek urgent care if you have severe or persistent abdominal pain, a swollen belly with no ability to pass gas or stool at all, or relentless vomiting. That combination can signal a bowel obstruction or ileus — the gut stalling — which is uncommon but serious. Ordinary constipation is a nuisance you manage; that picture is a reason to be seen promptly.

References

  1. Jalleh RJ, Rayner CK, Hausken T, Jones KL, Camilleri M, Horowitz M (2024). Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions. The Lancet Gastroenterology & Hepatology. https://pubmed.ncbi.nlm.nih.gov/39096914/
  2. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
  3. Chiang CH, Jaroenlapnopparat A, Colak SC, Yu CC, Xanthavanij N, Wang TH, et al. (2025). Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis. Gastroenterology. https://pubmed.ncbi.nlm.nih.gov/40499738/

Reported, not prescribed. Everything on this page is journalism and general education — not a diagnosis, a treatment plan, or a recommendation to start or stop any medication. Your history, hormones, and pregnancy plans are yours alone; only a licensed clinician who knows them can advise you. Talk to one before you act on anything you read here.